Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-27 @ 6:26 AM
Study NCT ID:
NCT00886457
Status:
TERMINATED
Last Update Posted:
2011-07-20
First Post:
2009-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates
Sponsor:
Nevada Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-21
First Submit QC Date:
None
Study First Post Date:
2009-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-19
Last Update Post Date:
2011-07-20
Last Update Post Date Type:
ESTIMATED